MASSAI, LARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.962
EU - Europa 2.596
AS - Asia 607
AF - Africa 12
OC - Oceania 7
SA - Sud America 5
Totale 7.189
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.952
PL - Polonia 856
RU - Federazione Russa 800
IT - Italia 340
IE - Irlanda 206
CN - Cina 177
SG - Singapore 174
HK - Hong Kong 146
SE - Svezia 135
DE - Germania 66
GB - Regno Unito 51
FI - Finlandia 50
IN - India 37
JO - Giordania 29
ES - Italia 17
BE - Belgio 14
FR - Francia 14
UA - Ucraina 13
CI - Costa d'Avorio 12
NL - Olanda 12
VN - Vietnam 12
CA - Canada 9
IL - Israele 8
AT - Austria 7
CH - Svizzera 7
AU - Australia 6
JP - Giappone 6
IR - Iran 5
TW - Taiwan 5
BG - Bulgaria 3
BR - Brasile 3
CO - Colombia 2
CZ - Repubblica Ceca 2
KR - Corea 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
EE - Estonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
Totale 7.189
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.243
Warsaw 856
Fairfield 430
Ashburn 237
Woodbridge 229
Chandler 219
Dublin 205
Houston 174
Seattle 165
Cambridge 159
Singapore 145
Florence 140
Wilmington 132
Ann Arbor 120
Hong Kong 99
Lawrence 77
Beijing 72
Altamura 71
Princeton 64
Buffalo 52
Boston 37
Shanghai 30
New York 28
Medford 27
Moscow 26
Mumbai 26
San Diego 21
Boardman 17
Helsinki 17
Brussels 14
Abidjan 12
Barcelona 12
Kent 12
Bristol 11
Jacksonville 11
Los Angeles 10
West Jordan 10
Dong Ket 8
London 8
Norwalk 8
Pistoia 8
Bologna 7
Munich 7
Redwood City 7
Toronto 7
Washington 7
Bern 6
Bremen 6
Falls Church 6
Frankfurt am Main 6
Phoenix 6
Vienna 6
Wuhan 6
Canberra 5
Falkenstein 5
Rehovot 5
Taipei 5
Cagliari 4
Gijón 4
Groningen 4
Guangzhou 4
Hillsboro 4
Lappeenranta 4
Serra 4
Verona 4
Empoli 3
Evanston 3
Fuzhou 3
Gainesville 3
Greenville 3
Göttingen 3
Hangzhou 3
Livorno 3
New Delhi 3
Prato 3
Pune 3
Redmond 3
Rome 3
Savannah 3
Shenzhen 3
Sofia 3
Tel Aviv 3
Yubileyny 3
Bogotá 2
Castelraimondo 2
Chengdu 2
Cleveland 2
Dearborn 2
Esslingen am Neckar 2
Glasgow 2
Gothenburg 2
Kensington 2
Laurel 2
Madison 2
Milan 2
Montespertoli 2
Montpellier 2
Nanjing 2
Naples 2
Napoli 2
Totale 5.459
Salva come PNG Salva come JPEG
Nome #
Proteomic analysis of the cytotoxic effects induced by the organogold(III) complex Aubipyc in cisplatin-resistant A2780 ovarian cancer cells: further evidence for the glycolytic pathway implication 260
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy(c.) 252
A first-in-class and a fished out anticancer platinum compound:: Cis -[PtCl2(NH3)2] and cis -[PtI2(NH3)2] compared for their reactivity towards DNA model systems 248
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 248
Evidence that the antiproliferative effects of auranofin in Saccharomyces cerevisiae arise from inhibition of mitochondrial respiration 244
Gold Compounds as Anticancer Agents: A Systematic Study of Gold–Protein Metalation 207
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 196
Reactions of model proteins with aurothiomalate, a clinically established gold(I) drug: The comparison with auranofin 175
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 167
Bioconjugations of proteins with 19F and nitroxide tags for in vitro and in cell characterization 159
Design, synthesis and characterisation of new chimeric ruthenium(ii)-gold(i) complexes as improved cytotoxic agents 152
Determinants for Tight and Selective Binding of a Medicinal Dicarbene Gold(I) Complex to a Telomeric DNA G-Quadruplex: a Joint ESI MS and XRD Investigation 146
Cytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivatives. 139
Chemistry and Biology of Two Novel Gold(I) Carbene Complexes as Prospective Anticancer Agents 138
Elucidating the reactivity of Pt(II) complexes with (O,S) bidentate ligands towards DNA model systems 138
The mode of action of anticancer gold-based drugs: a structural perspective 134
Antiproliferative properties and biomolecular interactions of three Pd(II) and Pt(II) complexes 132
Organogold(III) compounds as experimental anticancer agents: chemical and biological profiles 131
[Au(9-methylcaffein-8-ylidene)2]+/DNA Tel23 System: Solution, Computational, and Biological Studies 130
The leading established metal-based drugs: a revisitation of their relevant physico-chemical data 128
Chemistry and biology of three representative gold(III) compounds as prospective anticancer agents 123
Interactions of the organogold(III) compound Aubipyc with the copper chaperone Atox1: A joint mass spectrometry and circular dichroism investigation 119
Interaction of anticancer Ru(III) complexes with single stranded and duplex DNA model systems 116
Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin 114
Cisplatin binding to human serum albumin: a structural study 114
Size dependent biological profiles of PEGylated gold nanorods 112
The cisplatin/serum albumin system: A reappraisal 111
Interactions of Gold-based drugs with proteins: crystal structure of the adduct formed between Ribonuclease A and a cytotoxic gold(III) compound 106
Anticancer Ruthenium(III) Complex KP1019 Interferes with ATP-Dependent Ca(2+) Translocation by Sarco-Endoplasmic Reticulum Ca(2+) -ATPase (SERCA) 103
Interactions of selected gold(III) complexes with DNA G quadruplexes 99
Au2phen and Auoxo6, Two Dinuclear Oxo-Bridged Gold({III}) Compounds, Induce Apoptotic Signaling in Human Ovarian A2780 Cancer Cells 98
Inhibition of Na+/K+-ATPase and cytotoxicity of a few selected gold(III) complexes 92
Anticancer effects against colorectal cancer models of chloro(triethylphosphine)gold(I) encapsulated in PLGA–PEG nanoparticles 92
Reactions of Cytotoxic Metallodrugs with Lysozyme in pure DMSO explored through UV-Vis Absorption Spectroscopy and ESI MS 92
Protonation of cyclen-based chelating agents containing fluorescent moieties 91
Cell and Cell-Free Mechanistic Studies on Two Gold(III) Complexes with Proven Antitumor Properties 87
Selected Cytotoxic Gold Compounds cause Significant Inhibition of 20S Proteasome Catalytic Activities 84
Platinum(II) Complexes with O,S Bidentate Ligands: Biophysical Characterization, Antiproliferative Activity, and Crystallographic Evidence of Protein Binding 83
Gold compounds as cysteine protease inhibitors: perspectives for pharmaceutical application as antiparasitic agents 82
Direct detection of iron clusters in L ferritins through ESI-MS experiments 82
Cyclodextrin Inclusion Complexes of Auranofin and Its Iodido Analog: A Chemical and Biological Study 82
Bioconjugation of the gold drug auranofin to human ferritin yields a potent cytotoxin 81
Gold compounds: new anticancer drugs candidates. Studies of protein metalation processes 81
Pyrene-Containing Polyamines as Fluorescent Receptors for Recognition of PFOA in Aqueous Media 78
Structural evidences for a secondary gold binding site in the hydrophobic box of lysozyme 78
Reactions of Medicinal Gold(III) Compounds With Proteins and Peptides Explored by Electrospray Ionization Mass Spectrometry and Complementary Biophysical Methods 76
Gold-Based Metal Drugs as Inhibitors of Coronavirus Proteins: The Inhibition of SARS-CoV-2 Main Protease by Auranofin and Its Analogs 74
Mechanistic studies on cytotoxic gold compounds 73
Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties 73
Studies of cytotoxic gold compounds: interactions with model proteins and with the copper chaperone Atox-1 69
null 68
Medicinal gold compounds form tight adducts with the copper chaperone Atox-1: biological and pharmacological implications 68
Protein metalation by metal-based drugs: reactions of cytotoxic gold compounds with cytochrome c and lysozyme 68
Chemical Modification of Auranofin Yields a New Family of Anticancer Drug Candidates: The Gold(I) Phosphite Analogues 65
Proteomics as a tool to disclose the cellular and molecular mechanisms of selected anticancer gold compounds 63
19F: A small probe for a giant protein 62
The effects of two cytotoxic gold(i) carbene compounds on the metabolism of A2780 ovarian cancer cells: mechanistic inferences through NMR analysis 60
Comparative NMR metabolomics of the responses of A2780 human ovarian cancer cells to clinically established Pt-based drugs 59
NMR reveals the metabolic changes induced by auranofin in A2780 cancer cells: Evidence for glutathione dysregulation 59
Large Protein Assemblies for High-Relaxivity Contrast Agents: The Case of Gadolinium-Labeled Asparaginase 58
The effects of two gold-N-heterocyclic carbene (NHC) complexes in ovarian cancer cells: a redox proteomic study 57
Antiproliferative Properties of a Few Auranofin-Related Gold(I) and Silver(I) Complexes in Leukemia Cells and their Interferences with the Ubiquitin Proteasome System 57
Protein Metalation by Medicinal Gold Compounds: Identification of the Main Features of the Metalation Process through ESI MS Experiments 56
Mercury binding to proteins disclosed by ESI MS experiments: The case of three organomercurials 56
Na/K-ATPase as a target for anticancer metal based drugs: insights into molecular interactions with selected gold(iii) complexes 44
Unlocking the Power of Human Ferritin: Enhanced Drug Delivery of Aurothiomalate in A2780 Ovarian Cancer Cells 38
Dirhodium tetraacetate binding to a B-DNA double helical dodecamer probed by X-ray crystallography and mass spectrometry 32
null 31
null 21
null 18
Totale 7.329
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.917
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020690 0 0 0 0 0 120 112 131 111 80 109 27
2020/2021569 43 69 15 71 25 56 27 40 53 107 32 31
2021/2022436 16 37 28 16 17 23 13 35 25 24 88 114
2022/2023983 97 219 65 70 57 166 127 43 91 10 23 15
2023/2024574 19 38 74 23 34 62 33 119 15 35 75 47
2024/20252.612 133 326 211 454 1.048 440 0 0 0 0 0 0
Totale 7.329